Dupixenthcp.com Website Review

Make info private

Dupixenthcp.com receives about 2568 visitors in one month. That could possibly earn $12.84 each month or $0.43 each day. Server of the website is located in the United States. Dupixenthcp.com main page was reached and loaded in 0.47 seconds. This is a good result. Try the services listed at the bottom of the page to search for available improvements.

Traffic and Value

Is dupixenthcp.com legit?
Website Value	$232
Alexa Rank	1821241
Monthly Visits	2568
Daily Visits	86
Monthly Earnings	$12.84
Daily Earnings	$0.43

Click Here for Full Review

Dupixenthcp.com Server Location

Country: United States
Metropolitan Area: Not defined
Postal Reference Code: Not defined
Latitude: 37.751
Longitude: -97.822

The United States is a good location for your server if your website will be receiving most or at least decent part of visitors from Northern America. If you are planning to target mostly other regions you should consider using CDN or changing your server location.

Summarized Content

now approved as add-on maintenance treatment in patients (12+) with moderate-to-severe asthma with an eosinophilic phenotype or oral. now approved as add-on maintenance treatment in patients (12+) with moderate-to-severe asthma with an eosinophilic phenotype or oral corticosteroid dependent asthma limitation of use: dupixent is not indicated for the relief of. dupixent is a dual inhibitor of il-4 and il-13 signaling and is approved for 3 indications. limitation of use: dupixent is not indicated for the relief of acute bronchospasm or status asthmaticus the dupixent 300 mg pre-filled pen is available for appropriate patients aged 12+ years! controlled with topical prescription therapies or when those therapies are not advisable. dupixent can be used with or without topical phenotype or with oral corticosteroid dependent asthma. limitation of use: dupixent is not indicated for the relief of acute bronchospasm or dupixent® and dupixent myway® are registered trademarks of sanofi biotechnology forms are available at dupixenthcp.com. please ensure that you are filling out the correct form that corresponds to the appropriate first, allow the patient to review the patient authorization and certifications. then, ensure the patient has signed and dated twice at the top of the form where indicated, as it is vital to the process that the patient reads and agrees to both the patient authorization to help ensure a seamless enrollment process, ask the patient if they would like to provide their email address, mobile phone number, and to ensure that the healthcare provider has read and agrees to the healthcare provider certification, and signs and dates the populate the clinical information corresponding to your patient’s diagnosis. a list of potential codes is provided within the enrollment form for reference. be sure to provide only one icd-10 code, even if the patient has comorbid disease. once the primary icd-10 code is filled in and the form is completed, write the names of the patient and prescriber at the top of all pages.

Dupixenthcp Main Page Content

HTML Tag	Content	Informative?
Title:	DUPIXENT® (dupilumab) HCP	Could be improved
Description:	DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 3 indications. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on
H1:	Now Approved as Add-on Maintenance Treatment in Patients (12+) with Moderate-to-Severe Asthma with an Eosinophilic Phenotype or Oral Corticosteroid De
H2:	DUPIXENT is indicated:	Is it informative enough?
H3:	DUPIXENT MyWay ENROLLMENT FORMS	Is it informative enough?

Do you own dupixenthcp website?

We've noticed that you have issues with some content elements on the main page:
• Title contains 34 characters. We think that you could improve this tag by adding more relevant information or keywords.
• Take a look at the headings; there might be too little information. Headings are important for usability and search engine optimization.

Other Helpful Websites and Services for Dupixenthcp

Results will appear here

Pingdom - Web transfer-speed test from Pingdom
Run diagnostic transfer-rate tests on each page or individual page components (JS, .img, and HTML code) with Pingdom for dupixenthcp.com
Google’s Web Analytics Google provides many analytical tools for the web that will help you find out the number of visitors, their locations and activities when logging onto dupixenthcp.com
Alexa - dupixenthcp.com on Alexa Traffic Rank Data
Alexa provides a charting service that shows global position by audience, engagement, and time spent on dupixenthcp.com
Majestic Backlinks - Lookup other webpages that have hyperlinks leading to dupixenthcp.com.
Google Index - Which of the pages is Google.com indexing?
Find out which pages from dupixenthcp.com have made it into Google.com’s listings. You can find out with the "site:" query.
Website on this IP by Bing - All sites on the same 2600:1402:b800:59f::2b9c IP
View a list of websites with an IP matching that of dupixenthcp.com from Bing.com

Internal Pages

/update-during-covid-19-pandemic:
Title	DUPIXENT® (dupilumab) HCP Resources During COVID-19
Description	Find resources and patient support program updates to help answer questions your patients may have around DUPIXENT® (dupilumab) treatment during the current COVID-19 pandemic. Up-to-date clinical information covering COVID-19 is available online from professional medical ociations. [censored]
H1	NOTICE DURING COVID-19
H2	YOUR PATIENTS MAY HAVE QUESTIONS
H3	THE HEALTH AND SAFETY OF OUR CUSTOMERS AND PATIENTS ARE ALWAYS OUR PRIORITY

/atopicdermatitis:
Title	DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis That is Uncontrolled
Description	DUPIXENT® (dupilumab) is indicated for the treatment of patients aged 6 years and older with uncontrolled moderate-to-severe atopic dermatitis. Serious adverse reactions may occur. Please see Important Safety Information and full PI on website.
H1	Sustained Results.Lasting Relief.
H2	Check formulary status in your area

/asthma:
Title	DUPIXENT® (dupilumab) in Moderate-to-Severe Asthma \| HCP
Description	DUPIXENT® (dupilumab) is an add-on maintenance therapy for your moderate-to-severe asthma patients aged 12+ with an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: Not for the relief of acute bronchospasm or status asthmaticus. Serious adverse reactions may occur. Please see Important Safety Information and full PI on website.
H1	Discover a path to asthma control
H2	Significant efficacy across multiple endpoints

/crswnp:
Title	DUPIXENT® (dupilumab) in s with CRSwNP \| HCP Website [censored]
Description	DUPIXENT® (dupilumab) is indicated as an add-on maintenance treatment in patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP). Serious adverse reactions may occur. Please see Important Safety Information and full PI on website. [censored]
H1	Take a Different Path to CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (CRSwNP) control
H2	DUPIXENT IS THE FIRST BIOLOGIC APPROVED IN CRSwNP THAT TARGETS THE INFLAMMATION UNDERLYING THE DISEASE—SO YOUR PATIENTS CAN ACHIEVE AND MAINTAIN CONTROL

/atopicdermatitis/dosing-administration:
Title	DUPIXENT® (dupilumab) Dosage
Description	DUPIXENT® (dupilumab) is a subcutaneous injectable medication used in the treatment of patients aged 6 years and older with uncontrolled moderate-to-severe atopic dermatitis with two delivery options available, pre-filled syringe & pre-filled pen (aged 12+ years). Please see Dosage Regimens, How to Inject DUPIXENT® and Instructions for Use. Serious adverse reactions may occur. Please see Important Safety Information and full PI on website.
H1	Dosing and Administration
H2	Real patient treated with DUPIXENT.Individual results may vary.

All the information about dupixenthcp.com was collected from publicly available sources

Similar domain names

dupixentsupport.com dupixentteam.com dupixs.com dupixentdocumentcenter.com dupixentconnect.com dupixel.net

Recent Comments

Ronald Kurtz about trimbodymax.com

You took 89.95 and 84.95 at the same time from my back account that i didnt authorize and was apparently hacked. I...

Ester Joseph about repassists.com

Please refund my money back I never knew this am not interested

Jose Chavez about spoosk.com

Ive been charged for no reason this is fraud and want my money back!

CHANTREA BO about sitetaskreps.com

Good morning, Can you tell me what i have been charged for on 10/8/19 amount of $61..90 I believe this could be...

Leo Wickers IV about dotabon.com

Stop charging my account or police and better business bureau will be notified

tangi muzzo about attrdte.com

I need the money tht you took from my account.. I have no idea of what this site is all about.. Please return my...

Mthetheleli Peter about feemyd.com

This is a fraud I want my money back

motonobu matsubara about talentbrainstore.com

Please refund my 100yen and 10,000yen you took fraudulently as I never purchased or joined your site. Please cancel...

Selwyn Clarke about cartplay.com

Hi I sent an e-mail to you Thursday (nz) time and as yet I have had no response the number referred to is...

Nicolash Fernandes about ddos-guard.net

Knowing how reliable and secure DDoS protection service from ddos-guard.net, I have updated my plan with them and...

John about webtermdata.com

You have charged my credit card for $54.56 please add it back and cancel my subscription card ending 6485